Latest Diabetes: Drugs news
Bofanglutide Linked to Meaningful Reductions in HbA1c in Adults With T2DM
posted July 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Intranasal Insulin, Empagliflozin Have Promising Effects on Cognition
posted October 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Canagliflozin Tied to Reduction in HbA1c in Children, Teens With T2DM
posted August 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Glipizide Linked to Highest MACE-4 Risk in Individuals With Type 2 Diabetes
posted July 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers .jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk 
GLP-1 Receptor Agonist Use Does Not Increase Insulin Discontinuation With Type 2 Diabetes 
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy Monthly Specialist Briefings
Stay Connected
